# The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence

> **NCT03879759** · PHASE2 · UNKNOWN · sponsor: **South West Sydney Local Health District** · enrollment: 40 (estimated)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** NAC 2400mg/day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03879759
- **Lead sponsor:** South West Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-22
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879759, "The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03879759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*